… If this relationship applied to the situation in Laos, we would have seen considerably more
artemether-lumefantrine treatment failures. The differences may be explained by greater …

… falciparum malaria in Northern Laos. Although we found more treatment failures among
patients who received artemether-lumefantrine, this difference was not statistically significant. …

… Lao Government changed the national policy for uncomplicated Plasmodium falciparum
malaria from chloroquine to artemether-lumefantrine (… would help the Lao Government to make …

… The in vivo efficacies of the Lao People's Democratic Republic (Laos) nationally … The
efficacy of both chloroquine and sulfadoxine-pyrimethamine in Laos is unsatisfactory. …

… people) in the province [6]. The study was part of a multicentre trial conducted in Myanmar,
Vietnam, Cambodia and Laos to … treated with artemether/lumefantrine, as per the Lao national …

… day 7 blood or plasma lumefantrine concentrations for artemether-lumefantrine treatment of
… factors that cause substantial changes to these lumefantrine concentrations. For a drug with …

… Lao PDR is implementing strategies to ensure all malaria cases are detected and appropriately
treated with first-line artemisinin combination therapy, artemether–lumefantrine … Lao PDR …

… of reduced bioavailability of lumefantrine when taken without … Artemether-lumefantrine has
to be taken twice a day, which … 7 and the mean (95% CI) person-gametocyte-weeks did not …

… in Laos, we recently compared the efficacy of artesunate + mefloquine (AM), artemether–lumefantrine
(… falciparum malaria in Savannakhet Province, southern Laos. Cure rates at 42-day …

… approximately 80% in the Lao People’s Democratic Republic… an ACPR of 83% for
artemether-lumefantrine (AL) and K13 … critical next steps for the Lao People’s Democratic …